RE: Covid Testing Consultation12 Apr 2021 12:16
Sleepydave the reason i commented before is that the lack of an ISO13485 compliant quality management system is a huge problem as it is not only a requirement to CE mark but it also provides the basis and structure required behind the development process. The feasibility (Research) results from AVCT work look very promising but ive seen so many products in this space that worked extremely well when set up by the design experts within the discrete conditions of the R&D labs but then performed terrible in other hands either due to usability or environment.
The point is we just don't know anything about the development process of AVCT. It was developed not under a QMS so, to my mind, vital studies could have been missed. The one that springs to my mind the most is interfering substances where you test the diagnostic performance of the product in the presence of inhibitory compounds likely in the target samples to ensure it isn't affected.
I am categorically not saying that i KNOW AVCT dont have a conforming product, however, i am saying that if it makes it to market its process has been highly unusual as the timeline appears to indicate it started clinical trials before mologic were contracted to provide CE marking under their ISO13485 QMS.